Stay updated on Influenza Prevention with Self-Amplifying RNA Clinical Trial

Sign up to get notified when there's something new on the Influenza Prevention with Self-Amplifying RNA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Influenza Prevention with Self-Amplifying RNA Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer’s software revision number changed from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-18T16:51:25.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays Pfizer’s Phase 1 influenza saRNA vaccine study record, including its eligibility criteria, locations, design, and outcomes, instead of a 403 error screen.
    Difference
    89%
    Check dated 2026-11-11T17:52:21.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-28T15:59:18.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces an upcoming website transition and a change in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-21T20:51:51.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-14T20:51:50.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1; the page remains a 403 error page without study details.
    Difference
    0.2%
    Check dated 2026-10-07T21:38:00.000Z thumbnail image

Stay in the know with updates to Influenza Prevention with Self-Amplifying RNA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Influenza Prevention with Self-Amplifying RNA Clinical Trial page.